ICD-10 Code D65: Disseminated intravascular coagulation

Key Takeaways

ICD-10 Code D65 is the billable diagnosis code for disseminated intravascular coagulation (DIC), also known as defibrination syndrome.

D65 inclusion terms cover acquired afibrinogenemia, consumption coagulopathy, abnormal fibrinolysis, and (from 2026) COVID-19 associated coagulopathy.

D65 almost always functions as a secondary diagnosis: sequence the underlying triggering condition (sepsis, malignancy, obstetric complication) first.

Pabau’s claims management software helps coders flag sequencing errors before claims reach the payer, reducing avoidable denials.

ICD-10 Code D65: definition and official description

Most DIC denials trace back to one sequencing error: D65 coded as the principal diagnosis when the underlying trigger should lead the claim. Getting that order right starts with understanding exactly what the code covers.

ICD-10 Code D65 is the ICD-10-CM diagnostic code for Disseminated intravascular coagulation [defibrination syndrome]. The Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS) confirm it as a valid, billable diagnosis code. CMS approves it for use in all HIPAA-covered transactions, and it is valid for the 2026 fiscal year.

According to FindACode, the full code description was updated on 2026-04-01 — FindACode updated the full code description on 2026-04-01 to reflect the addition of COVID-19 associated coagulopathy as an inclusion term.

D65 sits within Chapter 3 of ICD-10-CM (Diseases of the Blood and Blood-Forming Organs, range D50-D89), specifically within the subcategory D65-D69: Coagulation defects, purpura and other hemorrhagic conditions. The World Health Organization’s ICD-10 classification provides the international framework on which ICD-10-CM is based, though CMS and NCHS maintain the clinical modification used in the United States.

Inclusion terms and synonyms

The official ICD-10-CM tabular list includes several terms under D65 that are considered equivalent for coding purposes. When any of these appear in the clinical documentation, D65 is the correct code assignment.

• Afibrinogenemia, acquired – fibrinogen has been consumed or destroyed by the coagulation cascade
• Consumption coagulopathy – the body consumes clotting factors and platelets faster than it can replace them
• COVID-19 associated diffuse or disseminated intravascular coagulopathy – added to the inclusion terms effective 2026-04-01; code D65 when COVID-19 (U07.1) triggers a coagulopathy meeting DIC criteria
• Abnormal fibrinolysis – pathological dissolution of clots leading to bleeding
• Fibrinolytic hemorrhage, acquired – hemorrhage arising from pathological fibrinolysis
• Fibrinolytic purpura – purpuric skin changes from fibrinolytic bleeding
• Purpura fulminans – rapidly progressive hemorrhagic necrosis, often associated with meningococcal sepsis

Coders should note that these terms are inclusion terms, not instructional notes. Their presence in physician documentation is sufficient to support D65 without additional diagnostic specificity. However, the underlying condition triggering DIC still requires its own separate code and should be sequenced first.

Clinical context: what causes DIC and who is at risk?

Disseminated intravascular coagulation is a serious hematologic emergency in which simultaneous clotting and bleeding occur throughout the body. It is never a primary disease: DIC is always triggered by an underlying condition that activates the coagulation cascade abnormally. Understanding the clinical triggers is essential for accurate sequencing in ICD-10-CM.

Common triggers of DIC

• Sepsis – the most common trigger in hospital settings, particularly gram-negative bacterial infections
• Obstetric complications – abruptio placentae, amniotic fluid embolism, eclampsia, and retained dead fetus
• Malignancy – especially acute promyelocytic leukemia (APL) and metastatic adenocarcinomas
• Trauma and burns – massive tissue injury releases thromboplastin into the circulation
• Transfusion reactions – incompatible blood products can precipitate acute DIC
• COVID-19 infection – severe COVID-19 can produce a coagulopathy meeting DIC criteria, now explicitly captured as an inclusion term under D65

The pathophysiology involves systemic activation of thrombin, leading to widespread microvascular fibrin deposition. This consumes platelets and coagulation factors (hence “consumption coagulopathy”), leaving the patient paradoxically prone to both thrombosis and hemorrhage. Laboratory findings typically include elevated D-dimer, prolonged PT and aPTT, low fibrinogen, and thrombocytopenia.

For inpatient coders, DIC presenting on admission versus DIC developing as a hospital-acquired complication has sequencing implications. Reviewing the admission history, lab trends, and physician attestation is essential before assigning D65.

Documentation requirements for accurate D65 coding

The ICD-10-CM Official Guidelines for Coding and Reporting require physician documentation to support every code assigned. For D65, three documentation elements are critical.

1. Physician attestation of DIC

The diagnosing clinician must use a term recognized by the ICD-10-CM index: disseminated intravascular coagulation, defibrination syndrome, consumption coagulopathy, or one of the other listed inclusion terms. Laboratory values alone do not justify the code assignment. If labs suggest DIC but the physician has not documented a clinical diagnosis, the coder must query before assigning D65. Good clinical documentation at your practice makes this query process faster and reduces rework cycles.

2. Identification of the underlying trigger

Because DIC is always secondary, the record must also document the triggering condition. Coders should not assign D65 without a corresponding principal or secondary code for sepsis, the obstetric complication, the malignancy, or whatever condition precipitated the DIC episode. Missing this co-code is the most common reason DIC claims are flagged in audit.

3. COVID-19 associated DIC

For COVID-19 associated coagulopathy that meets DIC criteria, assign both U07.1 (COVID-19) and D65. Sequence U07.1 first per ICD-10-CM guidelines on COVID-19 as the principal diagnosis when it is the underlying cause of additional manifestations. The 2026 addition of this inclusion term removes any ambiguity that existed in earlier code years. Accurate recording of these encounters supports population-level surveillance and appropriate DRG assignment.

Maintaining structured digital clinical forms that prompt physicians to document the DIC trigger at the point of care reduces the need for retrospective queries. For practices managing inpatient and outpatient records in parallel, structured patient records that capture lab trends alongside clinical notes give coders the context they need without chasing paper charts. For guidance on keeping these records HIPAA-compliant, see the HIPAA-compliant clinic software overview.

Reduce coding errors with smarter documentation workflows

Pabau helps clinical teams capture the diagnostic detail coders need at the point of care, so D65 and every other code gets the supporting documentation it requires before the claim is submitted.

Book a demo

ICD-10 Code D65 and related coagulation codes

Several other codes exist for coagulation disorders. Selecting the correct one depends on the specific condition documented. The table below summarizes the codes most frequently confused with D65, along with their distinguishing characteristics.

The distinction between D65 and D68.9 is the most common point of confusion. When the physician explicitly documents DIC, D65 is the correct assignment. D68.9 is a catch-all that should be used only when the documentation does not support a more specific code. Upcoding or downcoding between these two codes is a common focus in medical audit, so supporting documentation must be thorough.

For practices also coding related hematologic conditions, the intraparenchymal hemorrhage ICD-10 codes guide covers hemorrhagic complications that may co-occur with DIC episodes, particularly in critically ill patients. For broader guidance on complex ICD-10 coding guidelines for complex diagnoses that require careful sequencing, that reference covers the documentation logic applicable across multiple code categories. Coders working with anxiety-related codes alongside medical admissions may also find the situational anxiety ICD-10 code reference useful when psychiatric comorbidities appear alongside DIC in inpatient records.

DRG mapping and billing considerations

DIC codes carry significant weight in MS-DRG assignment because DIC frequently qualifies as a complication or comorbidity (CC) or major complication or comorbidity (MCC), which upgrades the DRG and increases reimbursement. The specific MS-DRG assigned depends on which condition leads the claim as the principal diagnosis.

Sequencing rules for D65

Coders should sequence D65 as a secondary diagnosis in almost all cases because DIC is, by definition, a complication of another condition. Under the ICD-10-CM Official Guidelines for Coding and Reporting, the underlying condition (sepsis, obstetric complication, malignancy) takes the principal diagnosis position. D65 then functions as an MCC on most inpatient claims, increasing the relative weight of the assigned MS-DRG compared to the same principal diagnosis coded without DIC.

The exception applies in rare cases where DIC itself is the reason for admission and the team has not yet identified the triggering condition, or it has resolved before the admission. In this scenario, query the physician before assigning D65 as the principal diagnosis: the clinical record must support that the DIC episode, not the underlying condition, drove the admission decision.

Inpatient vs. outpatient billing

DIC is predominantly an inpatient diagnosis. Outpatient assignment of D65 is uncommon and should be reviewed carefully. If a patient is seen in an outpatient setting for a follow-up related to a resolved DIC episode, code only the residual condition or the original underlying trigger, not D65, unless the physician documents active DIC at that encounter. The CMS ICD-10-CM coding guidance is explicit: a code should reflect the condition at the current encounter, not a historical diagnosis.

For practices using claims management software, automated claim scrubbing that flags D65 as the principal diagnosis without a corresponding trigger code can prevent a significant proportion of avoidable denials before they reach the payer. Practices managing mixed inpatient and outpatient billing will also benefit from reviewing general medical office compliance requirements to ensure coding workflows align with payer expectations.

Conclusion

DIC is one of the highest-acuity diagnoses in inpatient medicine, and accurate use of ICD-10 Code D65 directly affects both DRG weight and audit exposure. The critical rules are straightforward: sequence the trigger first, confirm physician attestation, and apply the 2026 COVID-19 inclusion term where documented.

Pabau’s AI-assisted clinical documentation helps clinicians capture the diagnostic language coders need at the point of care, reducing retrospective queries and supporting cleaner first-pass claim rates. To see how Pabau handles clinical documentation and coding workflows for complex inpatient diagnoses, book a demo.

Continue your research

Need a reference for hemorrhagic complication coding? Intraparenchymal hemorrhage ICD-10 codes covers hemorrhagic diagnoses that frequently co-occur with DIC in critically ill patients.

Looking for broader ICD-10-CM code guidance? ICD-10-CM diagnostic code reference provides a full index of Pabau’s ICD-10-CM coding guides organized by category and specialty.

Want to reduce documentation gaps before claim submission? Claims management software from Pabau automates claim scrubbing and flags sequencing errors before they reach the payer.

Frequently Asked Questions